<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<td align="center" colspan="1" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> <content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="center" colspan="1" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> <content stylecode="bold">Effect </content>
<content stylecode="bold">on </content>
<content stylecode="bold">Concentration </content>
<content stylecode="bold">of </content>
<content stylecode="bold">Lamotrigine </content>
<content stylecode="bold">or </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Concomitant </content>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td align="center" colspan="1" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> <content stylecode="bold">Clinical </content>
<content stylecode="bold">Comment </content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="3"> <paragraph>↓= Decreased (induces lamotrigine gluronidation). <br/>
</paragraph>
<paragraph>↑= Increased (inhibits lamotrigine glucuronidation).<br/>
</paragraph>
<paragraph>?= Conflicting data.<br/>
</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     " valign="top"> Estrogen-containing oral <br/>contraceptive preparations <br/>containing 30 mcg ethinylestradiol <br/>and 150 mcg levonorgestrel<br/>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine<br/>
<br/>
<br/>
<br/>
<br/>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     " valign="top"> Decreased lamotrigine levels <br/>approximately 50%.<br/>
<br/>
<br/>
<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> <br/>
</td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     " valign="top"> ↓ levonorgestrel<br/>
</td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     " valign="top"> Decrease in levonorgestrel component by 19%.<br/>
</td>
</tr>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     " valign="top"> Carbamazepine (CBZ) and <br/>CBZ epoxide<br/>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine<br/>
<br/>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     " valign="top"> Addition of carbamazepine decreases lamotrigine <br/>concentration approximately 40%.<br/>
<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> <br/>
</td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     " valign="top"> ? CBZ epoxide<br/>
</td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     " valign="top"> May increase CBZ epoxide levels<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Phenobarbital/Primidone<br/>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine<br/>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Decreased lamotrigine <br/>concentration approximately 40%.<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Phenytoin (PHT)<br/>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine<br/>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Decreased lamotrigine <br/>concentration approximately 40%<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Rifampin<br/>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> ↓ lamotrigine<br/>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> Decreased lamotrigine AUC <br/>approximately 40%<br/>
</td>
</tr>
<tr>
<td stylecode="     Toprule         Lrule          Rrule     " valign="top"> Valproate<br/>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     " valign="top"> ↑ lamotrigine<br/>
<br/>
</td>
<td align="center" stylecode="     Toprule         Lrule          Rrule     " valign="top"> Increased lamotrigine concentrations slightly <br/>more than 2-fold.<br/>
<br/>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule          Rrule     " valign="top"> <br/>
</td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     " valign="top"> ? valproate<br/>
</td>
<td align="center" stylecode="     Botrule         Lrule          Rrule     " valign="top"> Decreased valproate concentrations an average of <br/>25% over a 3-week period then stabilized in healthy volunteers; <br/>no change in controlled clinical trials in epilepsy patients.<br/>
<br/>
</td>
</tr>
</tbody>
</table>